🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo ELLIPTA device

Found 16 matching trials

A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.

PHASE2

This study will evaluate the efficacy and safety data of AZD8871 in patient...

Status

Completed

Location

Research Site

Start Date

2018-10-10

Trial ID

NCT03645434

Treatments Being Tested

AZD8871 Anoro® Ellipta®

A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

PHASE4

This study aims to provide data in adult participants with mild to moderate...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-04-14

Trial ID

NCT04813354

Treatments Being Tested

ELLIPTA BREEZHALER

To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma

PHASE4

This study is designed to assess the proportion of asthma subjects making c...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-11

Trial ID

NCT02195284

Treatments Being Tested

ELLIPTA DISKUS/ACCUHALER MDI TURBUHALER

Description of the Ability to Learn How to Handle Inhaler Devices in Asthma

Asthma is a major public health problem. The main treatments against asthma...

Status

Withdrawn

Location

Bordeaux University Hospital

Start Date

2017-12-01

Trial ID

NCT03175926

Treatments Being Tested

placebo Diskus®placebo Ellipta®Pulmicort® Turbuhaler®

DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

Subjects who have not used the ELLIPTA™ inhaler nor the DISKUS™ inhaler in ...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-05

Trial ID

NCT01868009

Treatments Being Tested

ELLIPTA DISKUS

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This is a Phase IV multi-center, randomized, open-label, cross-over, placeb...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-06-21

Trial ID

NCT02786927

Treatments Being Tested

Placebo ELLIPTA device Placebo capsules for use in HANDIHALER device Inhaler Preference Questionnaire Version 1 Inhaler Preference Questionnaire Version 2

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

The primary purpose of this study is to evaluate lung function and health r...

Status

Completed

Location

GSK Investigational Site

Start Date

2018-06-25

Trial ID

NCT03478696

Treatments Being Tested

budesonide/formoterol albuterol/salbutamol FF/UMEC/VI Placebo to match budesonide/formoterol tiotropium Placebo to match FF/UMEC/VI placebo to match tiotropium ELLIPTA MDI HandiHaler

Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to compare in COPD patients naïve to DPIs, the...

Status

Completed

Location

Novartis Investigative Site

Start Date

2015-09

Trial ID

NCT02551224

Treatments Being Tested

Patient preference questionnaire

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma

PHASE3

Inhaled corticosteroids (ICS) have a number of known class effects includin...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-10-09

Trial ID

NCT02483975

Treatments Being Tested

FF Placebo Montelukast Albuterol/Salbutamol

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

PHASE4

The purpose of this study was to compare dynamic inspiratory flow rates ach...

Status

Completed

Location

Novartis Investigative Site

Start Date

2015-12-16

Trial ID

NCT02596009

Treatments Being Tested

Breezhaler®Ellipta®Handihaler®

Previous Next